oral tirzepatide vs injectable semaglutide Lilly orforglipron GLP-1 phase 3 weight loss trial Tirzepatide vs Semaglutide: 2026 Clinical
Description
Fatigue and daytime tiredness Fatigue is officially listed as a Zepbound side effect, reported by about 5 to 7% of people in clinical trials, depending on dose
No routine monitoring change is needed
Therefore, in clinical practice, close monitoring of blood glucose levels is recommended for individuals with diabetes, particularly those receiving combination antidiabetic therapy or during the early phase of dose adjustment
B vitamins and folic acid
